Dr. Koyuncu is an experienced virologist and a serial entrepreneur. He was a founding employee of Forge Life Science, a successfully growing biotech startup. Prior to Forge Life Science, he worked at Princeton University where he generated several novel technologies. His Princeton IP formed a basis for two startup companies and has been licensed/optioned by Kadmon and Merck. Ph.D., University of Hamburg; Post-doc, Princeton University.
Hahn Kim, Ph.D. - Founder, Adviser
Dr. Kim has deep expertise in the area of organic chemistry. He is currently the founding director of the Princeton University Screening Center. He is also a co-founder of Chiromics, where his role was instrumental in Chiromics’ successful research collaborations with companies such as Pfizer, Merck, GSK and Genentech. Ph.D. and post-doc, Princeton University.
David H. Perlman, Ph.D. - Founder, Adviser
Dr. Perlman has two-decades of experience in the field of biological mass-spectrometry. He previously served as a Research Scientist and Director of Princeton's Collaborative Proteomics Center, where he orchestrated integrative systems science among quantitative biologists, chemists, and bioinformaticians and pioneered high-resolution quantitative mass spectrometry approaches. Ph.D. and post-doc, Boston University School of Medicine
Patrick Lam, Ph.D. - Adviser
Dr. Lam has over 27 years of research experience in the field of medicinal chemistry. He was formerly a director in the Discovery Chemistry Department at Bristol-Myers Squibb (BMS). He is the co-inventor of a total of eight clinical candidates and the blockbuster anticoagulant drug Eliquis®/Apixaban.
Lynn Enquist, Ph.D. - Adviser
Dr. Enquist is Henry L. Hillman Professor in Molecular Biology and Professor in the Princeton Neuroscience Institute at Princeton University. His research pioneered the field of study of herpesvirus invasion of the mammalian nervous system. He is a Fellow of the American Academy of Microbiology and the American Association for the Advancement of Sciences (AAAS), and is the president of the American Society for Microbiology.
Crescenta Biosciences is proud to announce a seed-funding partnership with Akoyat, A.S., an investment company located in Istanbul, Turkey, specializing in the life-sciences sector.
Crescenta is actively seeking additional interested investors. Please contact us if you would like to discuss the rich investment opportunities available at this phase of Crescenta's development.
Crescenta is actively expanding our team. We are hiring highly creative, motivated, and intelligent scientists and managers for positions at all levels. While there are no open posted positions at this time, please check for updates to this space for specific postings in the future.
If you believe that you may be a great fit for Crescenta, we invite you to contact email@example.com for employment-related information.